The introduction of this tax credit is anticipated to have a substantial impact on the state's health research landscape. By financially incentivizing contributions to research institutions, the bill seeks to enhance funding for pediatric cancer studies, potentially leading to advancements in treatment and care for affected children. This credit also aims to lessen the financial burden on businesses, thereby encouraging them to invest in charitable contributions within their local communities.
Summary
Senate Bill 112 introduces a tax credit aimed at promoting pediatric cancer research in Wisconsin. The bill allows business entities to claim a tax credit for contributions made to certified pediatric cancer research institutions. Specifically, the credit limits the maximum amount claimable by an entity to $2,500,000 per taxable year, emphasizing a commitment to supporting research efforts in this critical area of health.
Contention
While the motivations behind SB112 align with public health interests, there are notable points of contention regarding the structures of tax credits and business contributions. Some stakeholders express concerns about possible tax revenue losses for the state, arguing that such credits could divert funds away from essential public services. Additionally, there are ongoing debates about the equitable distribution of these benefits and whether the bill addresses broader cancer research needs beyond pediatric conditions.
Designating June 15, 2026, as "Elora Joyce Khan Pediatric Brain Cancer Awareness Day" in Pennsylvania to promote education, compassion, advocacy and research related to pediatric brain cancer.